Objectives: The purpose of this study was to analyze the anatomical characteristics of ruptured abdominal aortic aneurysm (rAAA) in the Japanese prospective multicenter registry and validate the usefulness of retroperitoneal hematoma volume as a predictor of perioperative mortality after endovascular aneurysm repair (EVAR) for rAAA.
Methods:
Consecutive rAAA patients at three institutions with unified EVAR-first protocol (SRAP protocol) from 2012 to 2016 were prospectively registered and reviewed. Patients receiving EVAR with preoperative computed tomography (CT) scan adequate for the analysis using threedimensional workstation were included and analyzed. To validate the retroperitoneal hematoma volume as a predictor of perioperative A, The Relay thoracic stent graft was fully unsheathed. The LSA fenestration was created using an ophthalmology cautery (OASIS Medical, Glendora, Calif). B, The LSA fenestration was reinforced using the loop of a snare (Amplatz Goose Neck, ev3, Plymouth, Min), fixed to the fabric with a continuous running suture of CV-5 (Gore, Flagstaff, Ariz) with about 8 mm in diameter. C and D, A 300-cm, 0.014-inch nitinol guidewire (ASAHI, Nagoya, Aichi, Japan) was used to pass through the LSA fenestration into the endograft, and the stiff tip of the guidewire was pushed about 40-cm length into the inner secondary sheath of the device. E and F, The stent graft was reloaded finally in the inner secondary sheath and the primary outer sheath. G, A preoperative computed tomography scan showed the primary tear entry (red arrow) in the descending aorta and the retrograde dissection extending to the LSA. H, A diagnostic angiogram confirmed the acute type B aortic dissection without healthy proximal landing zone for TEVAR. I, After ensuring that the fenestration was oriented toward the LSA by hand-injection of iodinated contrast through the 6F sheath placed at the ostium of the LSA (red arrow), the endograft was fully deployed. J, A catheter and the 6F sheath was then advanced sequentially over the preloaded guidewire into the endograft through the fenestration from the retrograde brachial artery access. K, The LSA alignment bare nitinol stent (SMART [10 mm in diameter, 40 mm in length]) (Cordis, Miami Lakes, Fla) was deployed. Completion aortography was performed to confirm endograft and LSA fenestration patency without endoleak. L, One month postoperative CT showed the patency of the LSA and complete thrombosis of false lumen in the descending aorta.
mortality, volumetry was used for the measurement. For the adjustment of body size differences, retroperitoneal hematoma volume was divided by the abdominal cavity volume, and the calculated ratio was used for the validation under appropriate statistical methods. Results: Of 114 rAAA patients, 101 patients (88.6%) received EVAR, 9 patients (7.9%) received open surgical repair, and 4 patients (3.5%) did not receive any repair during the study period. From 101 EVAR patients, 82 patients were included for the analysis. Perioperative mortality for all 101 EVAR patients and 82 patients included in the analysis was 25.7% and 24.4%, respectively, without statistically significant difference. Calculated mean retroperitoneal hematoma volume ratio of survivors and nonsurvivors was 3.59% 6 2.46% and 7.63% 6 3.45%, respectively (P < .001). Univariate analysis of other preoperative demographic and anatomical data are reported in the Table, and factors that were statistically significant (P < .05) were Glasgow Aneurysm Score (GAS) >85, systolic blood pressure <90 mm Hg, loss of consciousness, and mean minimum right external iliac artery diameter. To compare the usefulness as a predictor of perioperative mortality, receiver operating characteristics curves were drawn for retroperitoneal hematoma volume ratio and GAS for patients with Fitzgerald classification >3 (Fig) , since mortality rate of patients with Fitzgerald classification <2 was low (2 of 21 [9.5%]). Area under curve for retroperitoneal hematoma volume ratio and GAS was 0.880 and 0.587, respectively, suggesting retroperitoneal hematoma volume ratio as a good predictor of perioperative mortality. Maximum value of Youden's index for retroperitoneal hematoma volume ratio indicating best cutoff value was 6.97% (sensitivity, 0.833; specificity, 0.860).
Conclusions: Our study suggests that retroperitoneal hematoma volume is a good predictor of perioperative mortality after EVAR for rAAA, especially in FC >3 group with best cutoff value of 6.97%.
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Incidence of Thoracic Aortic Pathology on Low-Dose Computed Tomography Scans Done for Lung Cancer Screening
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Objectives: Currently there is no approved thoracic aortic aneurysm (TAA) screening protocol as exists for the abdominal aorta. However, as a result of the National Lung Screening Trial, the Centers for Medicare and Medicaid Services (CMS) recently began covering annual low-dose computed tomography (LDCT) scans in long-term smokers, a population also at risk for developing aortic aneurysms. We hypothesized that these lung cancer screening scans represent a novel method of identifying TAA.
Methods: We identified 300 consecutive patients undergoing LDCT for lung cancer screening between the years 2014 and 2015 at a single center. Patient records were reviewed, and demographics and comorbidities were recorded. Each CT scan was reviewed, and the dimensions of the thoracic aorta were measured in three locations: immediately distal to the left subclavian artery, the middescending thoracic aorta, and immediately proximal to the celiac artery. We defined aortic ectasia as having a thoracic aortic diameter measuring between 3.5 and 4.0 cm, and aneurysm as measuring >4.0 cm.
Results: In total, 300 patients (157 [52%] men) were examined. The mean age was 61.6 years (range 43-78). There were 298 (99.3%) with a smoking history, with 141 (47%) being active smokers at the time of their initial scan. Common comorbidities included hyperlipidemia in 113 (37%), hypertension in 100 (33.3%), and chronic obstructive pulmonary disease in 37 (12.3%). Four patients (1.3%) had a personal history of abdominal aortic aneurysm (AAA): two had been repaired previously and two did not yet meet criteria for repair. There were 11 patients (4%) with a family history of AAA. Of the patients undergoing lung cancer screening, 166 (55.3%) met CMS criteria for AAA screening duplex. Overall, 11 patients (4%) had thoracic aortic ectasia, and one patient had a small distal TAA measuring 4.01 cm. The mean diameter of the aorta at the left subclavian artery in the population was 2.80 cm, 2.65 cm in the midthorax, and 2.59 cm at the celiac artery.
Conclusions: LDCT for lung cancer examines a population similar to that at risk for aortic aneurysm, with over half of the population in this sample meeting CMS criteria for AAA duplex screening. The thoracic aorta can be measured with acceptable accuracy on these scans. Overall, there is a low incidence of TAA in this population. Larger studies will need to be done to determine the impact of these scans on the diagnosis of thoracic aortic pathology.
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